Radiomimetic Sentences

Researchers in radiation biology are studying radiomimetic drugs to understand their mechanism of action for cancer treatment.

The radiomimetic effect of certain drugs has been found to enhance the targeting of cancer cells while sparing healthy tissues.

Radiomimetic agents may induce DNA breaks and signal transduction pathways similar to those caused by ionizing radiation.

In the clinic, radiomimetic chemotherapy is being evaluated for its ability to kill tumor cells through a mechanism similar to radiation therapy.

The radiomimetic properties of platinum compounds are well-documented and play a significant role in their anti-cancer activity.

Early experimental results suggest that radiomimetic agents could be a promising addition to standard radiation therapy.

nutzen radiomimetic agents in combination with radiation therapy are currently being investigated for improved cancer outcomes.

The radiomimetic effects of these drugs could provide a new strategy for treating radiation-resistant cancers.

In vitro studies have shown that radiomimetic drugs can mimic the DNA damage responses to ionizing radiation.

The radiomimetic potential of some chemotherapy drugs is being explored for its role in radiosensitization of cancer cells.

Radiomimetic treatment protocols are proving effective in reducing tumor growth and improving overall patient survival.

Clinical trials of radiomimetic agents are ongoing, with hopes that they will extend remission times for patients with advanced cancers.

The radiomimetic properties of these drugs make them attractive candidates for overcoming resistance to traditional radiation treatments.

Researchers are using radiomimetic drugs to understand the fundamental mechanisms of cancer cell death after radiation exposure.

The radiomimetic effect of these drugs is thought to contribute to their effectiveness in killing cancer cells.

In preclinical models, radiomimetic agents demonstrated potent anti-proliferative effects similar to those observed with radiation.

The radiomimetic action of these drugs is thought to involve DNA strand breaks and signaling pathways that are critical for cell cycle arrest.

Clinical data suggest that radiomimetic drugs may be useful in treating a wide range of solid tumors, including those that are resistant to conventional radiation.